These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11501839)

  • 21. [Preliminary evaluation of adjuvant chemotherapy against stage Ib or II gastric cancer].
    Inada T; Kawakubo H; Ichikawa A; Ogata Y
    Gan To Kagaku Ryoho; 1999 Feb; 26(3):315-20. PubMed ID: 10065094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The potential role of Bcl-2 expression, apoptosis and cell proliferation (Ki-67 expression) in cases of gastric carcinoma and correlation with classic prognostic factors and patient outcome.
    Tsamandas AC; Kardamakis D; Tsiamalos P; Liava A; Tzelepi V; Vassiliou V; Petsas T; Vagenas K; Zolota V; Scopa CD
    Anticancer Res; 2009 Feb; 29(2):703-9. PubMed ID: 19331225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paradoxical effects by preoperative oral low-dose tegafur administration in human gastric carcinomas: enhanced apoptosis and increased intratumoral microvessel density.
    Goto E; Okamoto E; Adachi H; Fukuda Y; Ito H
    Oncol Rep; 2002; 9(5):1021-6. PubMed ID: 12168067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epithelial cell turnover, p53 and bcl-2 protein expression during oncogenesis of early and advanced gastric cancer in a Western population.
    Triantafyllou K; Kitsanta P; Karamanolis DG; Kittas C; Ladas SD
    Dig Liver Dis; 2008 Jan; 40(1):39-45. PubMed ID: 18063429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Significance of biological markers for predicting prognosis and selecting chemotherapy regimens of advanced gastric cancer patients between continuous infusion of 5-FU and a combination of 5-FU and cisplatin.
    Boku N; Ohtsu A; Yoshida S; Shirao K; Shimada Y; Hyodo I; Saito H; Miyata Y;
    Jpn J Clin Oncol; 2007 Apr; 37(4):275-81. PubMed ID: 17522103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of p53 protein and resistance to preoperative chemotherapy in locally advanced gastric carcinoma.
    Cascinu S; Graziano F; Del Ferro E; Staccioli MP; Ligi M; Carnevali A; Muretto P; Catalano G
    Cancer; 1998 Nov; 83(9):1917-22. PubMed ID: 9806649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The clinical predictivity of biomarkers of stage III-IV epithelial ovarian cancer in a prospective randomized treatment protocol.
    Silvestrini R; Daidone MG; Veneroni S; Benini E; Scarfone G; Zanaboni F; Villa A; Presti M; Danese S; Bolis G
    Cancer; 1998 Jan; 82(1):159-67. PubMed ID: 9428493
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apoptosis and apoptosis-associated gene products related to the response to neoadjuvant chemotherapy for gastric cancer.
    Satomi D; Takiguchi N; Koda K; Oda K; Suzuki H; Yasutomi J; Ishikura H; Miyazaki M
    Int J Oncol; 2002 Jun; 20(6):1167-71. PubMed ID: 12011994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Association between p53 expression and chemosensitivity in advanced and recurrent gastric cancer].
    Nakata B; Chung YS; Ogawa M; Maeda K; Inoue T; Yamashita Y; Sowa M
    Gan To Kagaku Ryoho; 1996 Jun; 23 Suppl 2():151-3. PubMed ID: 8678559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
    Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
    Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The nuclear transcription factor kappaB/bcl-2 pathway correlates with pathologic complete response to doxorubicin-based neoadjuvant chemotherapy in human breast cancer.
    Buchholz TA; Garg AK; Chakravarti N; Aggarwal BB; Esteva FJ; Kuerer HM; Singletary SE; Hortobagyi GN; Pusztai L; Cristofanilli M; Sahin AA
    Clin Cancer Res; 2005 Dec; 11(23):8398-402. PubMed ID: 16322301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of P-glycoprotein, HER-2/ErbB-2, p53, and Bcl-2 in primary tumor and metachronous lung metastases in patients with high-grade osteosarcoma.
    Ferrari S; Bertoni F; Zanella L; Setola E; Bacchini P; Alberghini M; Versari M; Bacci G
    Cancer; 2004 May; 100(9):1936-42. PubMed ID: 15112275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical impact of thymidine phosphorylase expression in gastric cancer.
    Noguchi T; Fujiwara S; Takeno S; Kai S; Mizuta A; Nagao Y; Uchida Y
    Oncol Rep; 2003; 10(3):561-6. PubMed ID: 12684624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thymidine phosphorylase expression in gastric carcinoma as a marker for metastasis.
    Konno S; Takebayashi Y; Higashimoto M; Katsube T; Kanzaki A; Kawahara M; Takenoshita S; Aiba M; Ogawa K
    Anticancer Res; 2003; 23(6D):5011-4. PubMed ID: 14981960
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemistry of p53, Bcl-2, and Ki-67 as predictors of chemosensitivity.
    Itaya M; Yoshimoto J; Kojima K; Kawasaki S
    Methods Mol Med; 2005; 110():213-27. PubMed ID: 15901938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of HER-2, p53 and Bcl-2 in patients with epithelial ovarian cancer.
    Malamou-Mitsi V; Crikoni O; Timotheadou E; Aravantinos G; Vrettou E; Agnantis N; Fountzilas G
    Anticancer Res; 2007; 27(2):1157-65. PubMed ID: 17465257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcome after curative resection for locally recurrent rectal cancer.
    Bedrosian I; Giacco G; Pederson L; Rodriguez-Bigas MA; Feig B; Hunt KK; Ellis L; Curley SA; Vauthey JN; Delclos M; Crane CH; Janjan N; Skibber JM
    Dis Colon Rectum; 2006 Feb; 49(2):175-82. PubMed ID: 16392024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bcl-2 protein expression correlates with better prognosis in patients with advanced non-small cell lung cancer.
    Shibata Y; Hidaka S; Tagawa Y; Nagayasu T
    Anticancer Res; 2004; 24(3b):1925-8. PubMed ID: 15274378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p53 protein overexpression as a predictor of the response to chemotherapy in gastric cancer.
    Nakata B; Chung KH; Ogawa M; Ogawa Y; Yanagawa K; Muguruma K; Inoue T; Yamashita Y; Onoda N; Maeda K; Sawada T; Sowa M
    Surg Today; 1998; 28(6):595-8. PubMed ID: 9681607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic role of angiogenesis and its correlations with thymidine phosphorylase and p53 expression in ductal adenocarcinoma of the pancreas.
    Jinfeng M; Kimura W; Sakurai F; Moriya T; Mizutani M; Hirai I
    Hepatogastroenterology; 2007 Sep; 54(78):1635-40. PubMed ID: 18019682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.